Stratasys has launched the J5 Digital Anatomy 3D printer to help create patient-specific models to enhance surgical preparation and elevate patient outcomes.

The printer is set to benefit medical device manufacturers, hospitals and research institutions by improving patient outcomes, accelerating product development and optimising operations.

The printer offers life-like anatomical models for pre-operative surgical planning, potentially reducing operating room time and costs.

These models also facilitate improved communication within medical teams and patients.

Stratasys said the printer is equipped to support the creation of biomechanically accurate materials, enabling the production of models that mimic human tissue, vasculature and skeletal structures.

This feature provides realistic haptic feedback for various procedures and supports imaging with true-to-life radiopacity characteristics.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the printer is designed to be compact and office-friendly, addressing the budget and space constraints often faced by institutions.

With its small footprint and lower total cost of ownership, the printer is accessible to a wide range of healthcare providers and researchers.

Last year, Stratasys signed an agreement with CollPlant Biotechnologies to develop and commercialise a solution for the industrial-scale bioprinting of tissues and organs.

The companies will initially collaborate on the development of a bioprinting solution for regenerative breast implants produced by CollPlant.